Sodium Nitroprusside Injection, Solution
Product Images NDC 71288-202

4 FDA label images from Meitheal Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 71288-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Sod0o 0000 01)

Structural Formula (Sod0o 0000 01)
Chemical structure diagram of sodium nitroprusside showing iron (Fe) centrally bonded to cyanide (CN) and nitrosyl (ON) groups within a complex anion, associated with sodium (Na) ions and water molecules (H2O).*
FDA Label Image

Figure (Sod0o 0000 02)

Figure (Sod0o 0000 02)
A metabolic pathway diagram illustrating the metabolism of Sodium Nitroprusside. The diagram shows the interactions involving nitroprusside, cyanide, cyanmethlg, hemoglobin, methemoglobin, and thiocyanate, as well as the role of active cytochromes and renal excretion.*
FDA Label Image

Principal Display Panel – Sodium Nitroprusside Injection, 50 mg Per 2 mL Vial Label (Sod0o 0000 03)

Principal Display Panel – Sodium Nitroprusside Injection, 50 mg Per 2 mL Vial Label (Sod0o 0000 03)
Label for Sodium Nitroprusside Injection 50 mg per 2 mL (25 mg per mL) in a 2 mL single-dose vial for intravenous infusion. The label includes usage instructions, manufacturer Meitheal Pharmaceuticals Inc., and barcodes. The label is primarily red and white with black and yellow text.*
FDA Label Image

Principal Display Panel – Sodium Nitroprusside Injection, 50 mg Per 2 mL Carton (Sod0o 0000 04)

Principal Display Panel – Sodium Nitroprusside Injection, 50 mg Per 2 mL Carton (Sod0o 0000 04)
Packaging label for Sodium Nitroprusside Injection, 50 mg per 2 mL (25 mg per mL), an intravenous infusion solution by Meitheal Pharmaceuticals Inc. The single-dose vial must be diluted before use and is labeled for intravenous infusion only. The label includes storage instructions, dilution guidance, and warnings about light protection and blood pressure monitoring during administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.